Effects/NNS
of/IN
Mercuric/JJ
Chloride/NN
on/IN
Gene/NN
Expression/NN
in/IN
NRK-52E/NN
Cells/NNS
./.
====================
Mercuric/JJ
chloride/NN
,/,
a/DT
model/NN
nephrotoxicant/JJ
was/VBD
used/VBN
to/TO
elucidate/VB
time-/NN
and/CC
dose-/NN
dependent/JJ
global/JJ
gene/NN
expression/NN
changes/NNS
associated/VBN
with/IN
proximal/JJ
tubular/JJ
toxicity/NN
./.
====================
Rat/NN
kidney/NN
cell/NN
lines/NNS
NRK-52E/NN
cells/NNS
were/VBD
exposed/VBN
for/IN
2/CD
,/,
6/CD
and/CC
12/CD
hours/NNS
and/CC
with/IN
3/CD
different/JJ
doses/NNS
of/IN
mercuric/JJ
chloride/NN
./.
====================
Cell/NN
viability/NN
assay/NN
showed/VBD
that/IN
mercuric/JJ
chloride/NN
had/VBD
toxic/JJ
effects/NNS
on/IN
NRK52E/NN
cells/NNS
causing/VBG
20/CD
%/NN
cell/NN
death/NN
(/(
IC20/CD
)/)
at/IN
40μM/JJ
concentration/NN
./.
====================
We/PRP
set/VBP
this/DT
IC20/NN
as/IN
high/JJ
dose/NN
concentration/NN
and/CC
1/5/CD
and/CC
1/25/CD
concentration/NN
of/IN
LC20/NN
were/VBD
used/VBN
as/IN
mid/JJ
and/CC
low/JJ
concentration/NN
,/,
respectively/RB
./.
====================
Analyses/NNS
of/IN
microarray/NN
data/NNS
revealed/VBD
that/IN
738/CD
genes/NNS
were/VBD
differentially/RB
expressed/VBN
(/(
more/RBR
than/IN
two-fold/RB
change/NN
and/CC
p＜0.05/NN
)/)
by/IN
low/JJ
concentration/NN
of/IN
mercuric/JJ
chloride/NN
at/IN
least/JJS
one/CD
time/NN
point/NN
in/IN
NRK-52E/NN
cells/NNS
./.
====================
317/CD
and/CC
2,499/CD
genes/NNS
were/VBD
differentially/RB
expressed/VBN
at/IN
mid/JJ
and/CC
high/JJ
concentration/NN
of/IN
mercuric/JJ
chloride/NN
,/,
respectively/RB
./.
====================
These/DT
deregulated/VBN
genes/NNS
showed/VBD
a/DT
primary/JJ
involvement/NN
with/IN
protein/NN
trafficking/VBG
(/(
CAV2/NN
,/,
CANX/NN
,/,
CORO1B/NN
)/)
,/,
detoxification/NN
(/(
GSTs/NNS
)/)
and/CC
immunity/NN
and/CC
defense/NN
(/(
HMOX1/NN
,/,
NQO1/NN
)/)
./.
====================
Several/JJ
of/IN
these/DT
genes/NNS
were/VBD
previously/RB
reported/VBD
to/TO
be/VB
upregulated/VBN
in/IN
proximal/JJ
tubule/NN
cells/NNS
treated/VBN
with/IN
nephrotoxicants/NNS
and/CC
might/MD
be/VB
aid/VBN
in/IN
promoting/VBG
the/DT
predictive/JJ
biomarkers/NNS
for/IN
nephrotoxicity/NN
./.
====================
Mercury/RB
is/VBZ
unique/JJ
among/IN
the/DT
heavy/JJ
metals/NNS
in/IN
that/DT
it/PRP
can/MD
exist/VB
in/IN
several/JJ
physical/JJ
and/CC
chemical/JJ
forms/NNS
,/,
including/VBG
elemental/JJ
mercury/NN
,/,
which/WDT
is/VBZ
a/DT
liquid/JJ
at/IN
room/JJ
temperature/NN
(/(
Zalups/NNS
,/,
2000/CD
)/)
./.
====================
Among/IN
the/DT
chemical/JJ
forms/NNS
of/IN
mercury/NN
,/,
the/DT
inorganic/JJ
species/NNS
are/VBP
far/RB
more/RBR
nephrotoxic/JJ
./.
====================
Renal/JJ
proximal/JJ
tubular/JJ
cells/NNS
represent/VBP
the/DT
primary/JJ
target/NN
site/NN
,/,
where/WRB
highly/RB
reactive/JJ
inorganic/JJ
mercury/NN
ions/NNS
rapidly/RB
accumulate/VBP
and/CC
induce/VBP
acute/JJ
or/CC
chronic/JJ
kidney/NN
injuries/NNS
(/(
Zalups/NNS
,/,
2000/CD
)/)
./.
====================
Despite/IN
the/DT
numerous/JJ
studies/NNS
the/DT
mechanisms/NNS
whereby/RB
this/DT
metal/JJ
exerts/VBZ
its/PRP$
negative/JJ
effects/NNS
in/IN
the/DT
kidney/NN
is/VBZ
not/RB
fully/RB
understood/VBN
./.
====================
One/CD
of/IN
the/DT
main/JJ
and/CC
common/JJ
mechanisms/NNS
behind/VBP
heavy/JJ
metal/JJ
toxicity/NN
has/VBZ
been/VBN
attributed/VBN
to/TO
oxidative/JJ
stress/NN
./.
====================
Mercury/NN
induces/VBZ
oxidative/JJ
stress/NN
and/CC
ROS/NN
production/NN
by/IN
binding/VBG
to/TO
intracellular/JJ
thiols/NNS
./.
====================
This/DT
metal/JJ
also/RB
cause/VBP
direct/JJ
damage/NN
to/TO
the/DT
mitochondrial/JJ
and/CC
microsome/NN
metabolism/NN
,/,
and/CC
modifies/VBZ
renal/JJ
cell/NN
membrane/NN
and/CC
tubular/JJ
polarity/NN
(/(
Lash/NN
and/CC
Zalups/NNS
,/,
1992/CD
)/)
./.
====================
Changes/NNS
in/IN
the/DT
expression/NN
of/IN
mRNA/NN
specifically/RB
expressed/VBN
in/IN
the/DT
injured/JJ
kidney/NN
cells/NNS
are/VBP
some/DT
of/IN
the/DT
earliest/JJS
events/NNS
that/WDT
accompany/VBP
renal/JJ
injury/NN
./.
====================
This/DT
is/VBZ
accompanied/VBN
by/IN
alterations/NNS
in/IN
the/DT
expression/NN
of/IN
other/JJ
genes/NNS
(/(
e./FW
g./FW
KIM1/NN
,/,
cystatin/NN
C/NN
,/,
clusterin/NN
and/CC
osteopontin/NN
)/)
that/WDT
contribute/VBP
either/CC
to/TO
cellular/JJ
repair/NN
or/CC
recovery/RB
of/IN
renal/JJ
function/NN
(/(
Amin/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
A/DT
number/NN
of/IN
approaches/NNS
have/VBP
been/VBN
used/VBN
to/TO
identify/VB
components/NNS
of/IN
the/DT
complex/NN
responses/NNS
to/TO
nephrotoxicants/NNS
,/,
which/WDT
are/VBP
not/RB
only/RB
potential/JJ
biomarkers/NNS
but/CC
also/RB
therapeutic/JJ
targets/NNS
./.
====================
Gene/NN
expression/NN
in/IN
acute/JJ
renal/JJ
failure/NN
has/VBZ
been/VBN
analyzed/VBN
with/IN
microarrays/NNS
in/IN
several/JJ
studies/NNS
(/(
Amin/NN
et/FW
al./FW
,/,
2004/CD
;/:
Huang/NNP
et/FW
al./FW
,/,
2001/CD
;/:
Safirstein/NN
,/,
2004/CD
)/)
./.
====================
However/RB
,/,
the/DT
results/NNS
vary/VBP
because/IN
of/IN
a/DT
lot/JJ
of/IN
potential/JJ
confounding/VBG
factor/NN
,/,
such/JJ
as/IN
species/NNS
difference/NN
,/,
injury/NN
difference/NN
,/,
microarray/NN
platform/NN
difference/NN
and/CC
dose/NN
and/CC
time/NN
difference/NN
./.
====================
Many/JJ
studies/NNS
identified/VBD
KIM1/NN
as/IN
potential/JJ
renal/JJ
marker/NN
through/IN
gene/NN
expression/NN
analyses/NNS
after/IN
kidney/NN
injury/NN
./.
====================
KIM1/NN
is/VBZ
a/DT
type/NN
I/CD
transmenbrane/JJ
protein/NN
that/WDT
is/VBZ
not/RB
detectable/JJ
in/IN
normal/JJ
kidney/NN
but/CC
is/VBZ
expressed/VBN
at/IN
high/JJ
levels/NNS
in/IN
proximal/JJ
tubule/NN
epithelial/JJ
cells/NNS
after/IN
toxic/JJ
injury/NN
(/(
Ferguson/NN
et/FW
al./FW
,/,
2008/CD
;/:
Ichimura/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Recently/RB
,/,
the/DT
United/JJ
States/NNS
Food/NN
and/CC
Drug/NN
Administration/NN
and/CC
European/JJ
Medicines/NNS
Agency/NN
have/VBP
adopted/VBN
KIM1/NN
as/IN
a/DT
standard/JJ
biomarker/NN
for/IN
the/DT
preclinical/JJ
safety/NN
evaluation/NN
of/IN
novel/JJ
drug/NN
candidates/NNS
./.
====================
While/IN
KIM1/NN
was/VBD
adopted/VBN
as/IN
a/DT
biomarker/NN
of/IN
renal/JJ
toxicity/NN
,/,
several/JJ
studies/NNS
were/VBD
undertaken/VBN
in/IN
order/NN
to/TO
evaluate/VB
the/DT
utility/NN
of/IN
other/JJ
putative/JJ
renal/JJ
toxicity/NN
biomarkers/NNS
./.
====================
To/TO
circumvent/JJ
inconsistency/NN
caused/VBD
by/IN
confounding/VBG
factors/NNS
in/IN
in/FW
vivo/FW
studies/NNS
,/,
we/PRP
set/VBP
an/DT
in/FW
vitro/FW
study/NN
model/NN
for/IN
nephrotoxicity/NN
by/IN
using/VBG
a/DT
rat/NN
kidney/NN
epithelium/NN
originated/VBN
cell/NN
line/NN
,/,
NRK52/NN
./.
====================
To/TO
address/VB
biological/JJ
effect/NN
of/IN
mercuric/JJ
chloride/NN
on/IN
the/DT
cell/NN
line/NN
,/,
Rat/NN
Genome/NN
Survey/NN
Arrays/NNS
array/NN
was/VBD
used/VBN
to/TO
determine/VB
gene/NN
expression/NN
pattern/NN
elicited/VBD
by/IN
mercuric/JJ
chloride/NN
in/IN
NRK52E/NN
kidney/NN
cell/NN
lines/NNS
./.
====================
Mercuric/JJ
chloride/NN
was/VBD
purchased/VBN
Sigma/NN
(/(
St./NNP
Louis/NN
,/,
MO/NN
,/,
USA/NN
)/)
./.
====================
DMEM/NN
,/,
Fetal/JJ
bovine/JJ
serum/NN
(/(
FBS/NN
)/)
,/,
penicillin/streptomycin/NN
,/,
TRIzol/NN
and/CC
DEPC-treated/JJ
water/NN
were/VBD
obtained/VBN
from/IN
Invitrogen/NN
(/(
Carlsbad/NN
,/,
CA/NNP
,/,
USA/NN
)/)
./.
====================
NRK-52E/NN
cell/NN
line/NN
,/,
a/DT
rat/NN
renal/JJ
proximal/JJ
tubular/JJ
cell/NN
,/,
were/VBD
cultured/VBN
in/IN
DMEM/F-12/NN
(/(
50/50/CD
)/)
medium/NN
supplemented/VBN
with/IN
10/CD
%/NN
heat-inactivated/VBN
FBS/NN
,/,
0.02M/CD
NaHCO3/NN
,/,
100/CD
U/ml/NN
penicillin/NN
and/CC
100/CD
mg/ml/NN
streptomycin/NN
and/CC
maintained/VBD
in/IN
monolayer/JJ
culture/NN
at/IN
37oC/NN
in/IN
an/DT
incubator/NN
of/IN
humidified/JJ
air/NN
with/IN
5/CD
%/NN
CO2/NN
./.
====================
Subconfluent/JJ
cells/NNS
(/(
80/CD
%/NN
)/)
were/VBD
passaged/VBN
with/IN
a/DT
solution/NN
containing/VBG
0.05/CD
%/NN
trypsin/NN
and/CC
0.02/CD
%/NN
EDTA/NN
./.
====================
NRK-52E/NN
cells/NNS
were/VBD
treated/VBN
with/IN
test/NN
substances/NNS
dissolved/JJ
in/IN
PBS/NN
for/IN
12/CD
h./FW
After/IN
the/DT
treatment/NN
,/,
cell/NN
viability/NN
was/VBD
assessed/VBN
using/VBG
MTT/NN
assay/NN
kit/NN
(/(
Sigma/NN
,/,
St./NNP
Louis/NN
,/,
MO/NN
,/,
USA/NNP
)/)
./.
====================
The/DT
cell/NN
culture/NN
medium/NN
was/VBD
withdrawn/IN
by/IN
remaining/VBG
100μl/well/RB
at/IN
the/DT
end/NN
of/IN
exposure/NN
time/NN
./.
====================
An/DT
addition/NN
of/IN
10μl/well/JJ
MTT/NN
stock/NN
solution/NN
(/(
5/CD
mg/ml/NN
)/)
is/VBZ
followed/VBN
by/IN
an/DT
incubation/NN
period/NN
of/IN
4h/JJ
(/(
37oC/NN
,/,
5/CD
%/NN
CO2/NN
)/)
./.
====================
Afterwards/IN
100μl/well/CD
solubilization/NN
solution/NN
was/VBD
added/VBN
,/,
followed/VBN
by/IN
a/DT
mixing/JJ
./.
====================
A/DT
kinetic/JJ
assay/NN
was/VBD
performed/VBN
by/IN
measuring/VBG
its/PRP$
absorbance/NN
(/(
570/CD
nm/NN
)/)
in/IN
a/DT
SpectraMax/NN
microplate/NN
reader/NN
(/(
Molecular/JJ
Devices/NNS
,/,
Sunnyvale/JJ
,/,
CA/NNP
,/,
USA/NN
)/)
./.
====================
Absorbance/NN
values/NNS
were/VBD
obtained/VBN
from/IN
more/RBR
than/IN
three/CD
independent/JJ
experiments/NNS
./.
====================
Mercuric/JJ
chloride/NN
was/VBD
treated/VBN
with/IN
1/25/CD
of/IN
IC20/NN
(/(
1.6μM/CD
,/,
low/JJ
)/)
,/,
1/5/CD
of/IN
IC20/NN
(/(
8μM/NN
,/,
mid/JJ
)/)
or/CC
IC20/NN
(/(
40μM/JJ
,/,
high/JJ
)/)
,/,
and/CC
total/JJ
RNA/NN
were/VBD
obtained/VBN
at/IN
2/CD
,/,
6/CD
or/CC
12/CD
h/NN
after/IN
initial/JJ
treatment/NN
./.
====================
Total/JJ
RNA/NN
was/VBD
extracted/VBN
from/IN
each/DT
time/NN
and/CC
dose/NN
point/NN
using/VBG
Trizol/NN
in/IN
accordance/NN
with/IN
the/DT
manufacturer/NN
’/CD
s/NNS
procedures/NNS
./.
====================
The/DT
quality/NN
of/IN
the/DT
total/JJ
RNA/NN
was/VBD
assessed/VBN
using/VBG
an/DT
Agilent/JJ
2100/CD
Bioanalyzer/NN
./.
====================
RNA/NN
quantification/NN
and/CC
purity/NN
(/(
260/280/CD
ratio/NN
)/)
were/VBD
determined/VBN
with/IN
a/DT
UV/VIS/NN
spectrophotometer/NN
(/(
ND-1000/CD
,/,
NanoDrop/NN
Technologies/NNS
,/,
Wilmington/JJ
,/,
DE/NN
,/,
USA/NN
)/)
./.
====================
The/DT
Applied/JJ
Biosystems/NNS
Rat/NN
Genome/NN
Survey/NN
Arrays/NNS
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
,/,
which/WDT
contain/VBP
60mer/JJ
oligonucleotide/NN
probes/NNS
representing/VBG
a/DT
set/NN
of/IN
32,878/CD
individual/JJ
mouse/NN
genes/NNS
and/CC
more/RBR
than/IN
250/CD
control/NN
probes/NNS
,/,
were/VBD
used/VBN
for/IN
differential/JJ
gene/NN
expression/NN
profiles/NNS
./.
====================
Microarray/NN
experiments/NNS
were/VBD
performed/VBN
according/VBG
to/TO
the/DT
manufacturerjs/NNS
instructions/NNS
./.
====================
Digoxigenin/NN
(/(
DIG/NN
)/)
UTPlabeled/JJ
cRNA/NN
was/VBD
generated/VBN
from/IN
5μg/JJ
of/IN
total/JJ
RNA/NN
and/CC
amplified/VBD
using/VBG
a/DT
chemiluminescent/JJ
reverse/JJ
transcription/NN
(/(
RT/NN
)/)
in/IN
vitro/FW
transcription/NN
labeling/NN
kit/NN
(/(
Applied/VBN
Biosystems/NNS
)/)
./.
====================
Briefly/RB
,/,
each/DT
microarray/NN
was/VBD
prehybridized/VBN
in/IN
hybridization/NN
buffer/NN
with/IN
blocking/VBG
reagent/JJ
at/IN
55oC/JJ
for/IN
1/CD
h./FW
DIGlabeled/JJ
cRNA/NN
targets/NNS
(/(
10μg/CD
)/)
were/VBD
fragmented/JJ
to/TO
100∼400/CD
bp/NN
and/CC
hybridized/VBD
with/IN
each/DT
prehybridized/VBN
microarray/NN
at/IN
55oC/JJ
for/IN
16/CD
h./FW
The/DT
arrays/NNS
were/VBD
washed/VBN
with/IN
hybridization/NN
wash/NN
buffer/NN
and/CC
then/RB
with/IN
chemiluminescence/NN
rinse/NN
buffer/NN
./.
====================
Chemiluminescent/JJ
signals/NNS
were/VBD
generated/VBN
by/IN
incubating/VBG
the/DT
arrays/NNS
with/IN
antiDIGalkaline/JJ
phosphatase/NN
and/CC
chemiluminescence/NN
substrate/NN
./.
====================
Images/NNS
were/VBD
collected/VBN
for/IN
each/DT
microarray/NN
using/VBG
the/DT
1700/CD
Chemiluminescent/JJ
Microarray/NN
Analyzer/NN
(/(
Applied/VBN
Biosystems/NNS
)/)
./.
====================
Microarray/NN
images/VBZ
were/VBD
autogridded/VBN
,/,
and/CC
the/DT
chemiluminescent/JJ
signals/NNS
were/VBD
quantified/VBN
,/,
corrected/VBD
for/IN
background/NN
,/,
spatially/RB
normalized/VBN
,/,
and/CC
exported/VBD
for/IN
a/DT
quality/NN
report/VBP
./.
====================
Microarray/NN
data/NNS
with/IN
quality/NN
reports/NNS
above/JJ
the/DT
manufacturer/NN
's/POS
threshold/NN
were/VBD
used/VBN
for/IN
further/JJ
analysis/NN
./.
====================
Signal/NN
intensities/NNS
were/VBD
imported/VBN
into/IN
GenPlex/NN
software/RB
(/(
Istech/NNP
,/,
Korea/NN
)/)
,/,
where/WRB
interarray/JJ
quantile/RB
normalization/NN
was/VBD
performed/VBN
to/TO
minimize/VB
the/DT
effect/NN
of/IN
external/JJ
variables/NNS
that/DT
might/MD
be/VB
introduced/VBN
into/IN
the/DT
data/NNS
./.
====================
Quality/NN
filtering/VBG
of/IN
unreliable/JJ
spots/NNS
(/(
flag/NN
value＜100/NN
and/CC
S/N＜2/NN
)/)
was/VBD
performed/VBN
before/IN
normalization/NN
./.
====================
Then/RB
,/,
the/DT
expression/NN
intensities/VBZ
were/VBD
log2/NN
transformed/VBN
./.
====================
We/PRP
took/VBD
the/DT
average/NN
value/NN
from/IN
the/DT
gene/NN
expression/NN
ratio/NN
obtained/VBN
in/IN
three/CD
biological/JJ
replicates/VBZ
./.
====================
DEGs/NNS
were/VBD
selected/VBN
on/IN
the/DT
basis/NN
of/IN
ratios/NNS
(/(
fold/JJ
change＞2/NN
)/)
and/CC
Welch/JJ
’/CD
s/NNS
ttest/JJS
(/(
p＜0.05/NN
)/)
./.
====================
Additionally/RB
,/,
DEGs/NNS
were/VBD
categorized/VBN
according/VBG
to/TO
their/PRP$
biological/JJ
processes/NNS
using/VBG
the/DT
PANTHER/NN
(/(
Protein/NN
ANalysis/NN
THrough/JJ
Evolutionary/JJ
Relationships/NNS
)/)
protein/NN
classification/NN
system/NN
(/(
www/NN
./.
====================
pantherdb/NN
./.
====================
org/NN
,/,
Mi/NNP
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
The/DT
PANTHER/NN
system/NN
provides/VBZ
probability/NN
of/IN
each/DT
biological/JJ
process/NN
by/IN
comparing/VBG
the/DT
DEG/NN
list/NN
to/TO
the/DT
reference/NN
list/NN
containing/VBG
all/DT
the/DT
probes/NNS
present/JJ
on/IN
the/DT
array/NN
./.
====================
The/DT
over/downrepresentation/NN
of/IN
each/DT
biological/JJ
process/NN
is/VBZ
determined/VBN
by/IN
Fisher/NN
’/CD
s/NNS
exact/JJ
test/NN
in/IN
combination/NN
with/IN
Bonferroni/NN
correction/NN
for/IN
multiple/JJ
testing/VBG
./.
====================
Cell/NN
viability/NN
following/VBG
treatment/NN
with/IN
mercuric/JJ
chlorideThe/DT
effect/NN
of/IN
mercuric/JJ
chloride/NN
on/IN
NRK52E/NN
cells/NNS
was/VBD
monitored/VBN
by/IN
MTT/NN
assay/NN
./.
====================
Based/VBN
on/IN
the/DT
results/NNS
of/IN
MTT/NN
assay/NN
,/,
the/DT
20/CD
%/NN
cell/NN
viability/NN
inhibition/NN
concentration/NN
(/(
IC20/CD
)/)
of/IN
mercuric/JJ
chloride/NN
was/VBD
calculated/VBN
from/IN
nonlinear/JJ
regression/NN
analysis/NN
./.
====================
As/IN
a/DT
result/NN
,/,
the/DT
IC20/NN
value/NN
of/IN
mercuric/JJ
chloride/NN
in/IN
NRK-52E/NN
cells/NNS
was/VBD
found/VBN
to/TO
be/VB
40/CD
μM/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Mercuric/JJ
chloride/NN
was/VBD
treated/VBN
to/TO
NRK-52E/NN
cells/NNS
at/IN
a/DT
concentration/NN
of/IN
1/25/CD
of/IN
IC20/NN
(/(
1.6μM/CD
,/,
low/JJ
)/)
,/,
1/5/CD
of/IN
IC20/NN
(/(
8μM/NN
,/,
mid/JJ
)/)
or/CC
IC20/NN
(/(
40μM/JJ
,/,
high/JJ
)/)
for/IN
2/CD
,/,
6/CD
,/,
12/CD
h/NN
and/CC
0h/JJ
(/(
the/DT
control/JJ
)/)
./.
====================
Total/JJ
RNA/NN
isolated/VBN
from/IN
NRK52E/NN
cells/NNS
were/VBD
subjected/VBN
to/TO
each/DT
microarray/NN
experiment/NN
./.
====================
For/IN
each/DT
dose/NN
treatment/NN
(/(
low/JJ
,/,
mid/JJ
and/CC
high/JJ
)/)
,/,
genes/NNS
with/IN
statistically/RB
significant/JJ
expression/NN
changes/NNS
were/VBD
identified/VBN
using/VBG
fold/JJ
change/NN
(/(
fold＞2/CD
)/)
and/CC
Welch/JJ
’/CD
s/NNS
ttest/JJS
(/(
p＜0.05/NN
)/)
./.
====================
For/IN
low-concentration/JJ
mercuric/JJ
chloride/NN
treatment/NN
group/NN
,/,
738/CD
genes/NNS
were/VBD
significantly/RB
expressed/VBN
＞2fold/RB
with/IN
p＜0.05/NN
at/IN
least/JJS
at/IN
one/CD
time/NN
point/NN
during/IN
the/DT
experiment/NN
./.
====================
In/IN
detail/NN
,/,
we/PRP
found/VBD
229/CD
up-regulated/VBD
genes/NNS
and/CC
72/CD
down-regulated/VBN
genes/NNS
on/IN
2/CD
h/NN
,/,
137/CD
upregulated/VBN
genes/NNS
and/CC
129/CD
genes/NNS
were/VBD
down-regulated/VBN
on/IN
6h/JJ
and/CC
175/CD
up-regulated/VBD
genes/NNS
and/CC
242/CD
down-regulated/VBN
genes/NNS
on/IN
12h/NN
respectively/RB
./.
====================
738/CD
differentially/RB
expressed/VBN
genes/NNS
in/IN
low/JJ
treatment/NN
group/NN
were/VBD
individually/RB
annotated/JJ
,/,
and/CC
the/DT
predominant/JJ
biological/JJ
processes/NNS
represented/VBN
by/IN
these/DT
genes/NNS
were/VBD
identified/VBN
using/VBG
PANTHER/NN
approach/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
,/,
the/DT
most/JJS
significantly/RB
overrepresented/VBN
biological/JJ
processes/NNS
were/VBD
“/RB
protein/NN
metabolism/NN
and/CC
modification/NN
”/CD
,/,
“/NNP
nucleic/JJ
acid/NN
metabolism/NN
”/CD
,/,
“/NNP
intracellular/JJ
protein/NN
traffic/JJ
”/CD
,/,
“/NNP
cell/NN
cycle/NN
”/NN
and/CC
“/NN
cell/NN
structure/NN
and/CC
motility/NN
”/CD
./.
====================
Among/IN
them/PRP
,/,
many/JJ
“/NN
intracellular/JJ
protein/NN
traffic/JJ
”/CD
-related/JJ
genes/NNS
showed/VBD
expression/NN
pattern/NN
of/IN
consistent/JJ
up-regulation/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
For/IN
mid-concentration/NN
mercuric/JJ
chloride/NN
treatment/NN
group/NN
,/,
317/CD
genes/NNS
were/VBD
significantly/RB
expressed/VBN
＞2fold/RB
with/IN
p＜0.05/NN
at/IN
least/JJS
at/IN
one/CD
time/NN
point/NN
during/IN
the/DT
experiment/NN
./.
====================
In/IN
detail/NN
,/,
we/PRP
found/VBD
121/CD
up-regulated/VBD
genes/NNS
and/CC
69/CD
down-regulated/VBN
genes/NNS
on/IN
2/CD
h/NN
,/,
107/CD
upregulated/VBN
genes/NNS
and/CC
28/CD
down-regulated/VBN
genes/NNS
on/IN
6h/JJ
and/CC
38/CD
up-regulated/VBD
genes/NNS
and/CC
25/CD
down-regulated/VBN
genes/NNS
on/IN
12/CD
h/NN
respectively/RB
./.
====================
Changes/NNS
in/IN
the/DT
expression/NN
of/IN
genes/NNS
related/JJ
to/TO
“/CD
detoxification/NN
”/CD
were/VBD
significantly/RB
overrepresented/VBN
in/IN
the/DT
317/CD
differentially/RB
expressed/VBN
genes/NNS
of/IN
mid/JJ
treatment/NN
group/NN
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
Interestingly/RB
,/,
genes/NNS
related/JJ
to/TO
“/CD
detoxification/NN
”/CD
were/VBD
shown/VBN
more/RBR
than/IN
2/CD
fold/JJ
expression/NN
changes/NNS
in/IN
the/DT
6h/JJ
time/NN
point/NN
mainly/RB
(/(
Table/JJ
2/CD
)/)
./.
====================
It/PRP
was/VBD
found/VBN
that/IN
most/JJS
genes/NNS
in/IN
this/DT
category/NN
were/VBD
glutathioneStransferases/NNS
./.
====================
For/IN
highconcentration/JJ
mercuric/JJ
chloride/NN
treatment/NN
group/NN
,/,
2,499/CD
genes/NNS
were/VBD
significantly/RB
expressed/VBN
＞2/CD
fold/JJ
with/IN
p＜0.05/NN
at/IN
least/JJS
at/IN
one/CD
time/NN
point/NN
during/IN
the/DT
experiment/NN
./.
====================
In/IN
detail/NN
,/,
we/PRP
found/VBD
141/CD
upregulated/VBN
genes/NNS
and/CC
21/CD
were/VBD
down-regulated/VBN
genes/NNS
on/IN
2/CD
h/NN
,/,
716/CD
up-regulated/VBD
genes/NNS
and/CC
410/CD
down-regulated/VBN
genes/NNS
on/IN
6h/JJ
and/CC
977/CD
up-regulated/VBD
genes/NNS
and/CC
1,112/NN
downregulated/VBD
genes/NNS
on/IN
12/CD
h/NN
respectively/RB
./.
====================
Based/VBN
on/IN
PANTHER/NN
analysis/NN
,/,
high-concentration/JJ
mercuric/JJ
chloride/NN
treatment/NN
group/NN
resulted/VBD
enrichment/JJ
of/IN
many/JJ
biological/JJ
processes/NNS
,/,
such/JJ
as/IN
“/RB
sensory/JJ
perception/NN
”/NNP
,/,
“/NNP
protein/NN
targeting/VBG
and/CC
localization/NN
”/NNP
,/,
“/NNP
protein/NN
metabolism/NN
and/CC
modification/NN
”/RB
,/,
“/NNP
nucleic/JJ
acid/NN
metabolism/NN
”/RB
,/,
“/NNP
neuronal/JJ
activities/NNS
”/RB
,/,
“/NNP
cell/NN
proliferation/NN
and/CC
differentiation/NN
”/CD
and/CC
“/FW
cell/NN
cycle/NN
”/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
The/DT
overlapping/JJ
of/IN
differentially/RB
expressed/VBN
genes/NNS
in/IN
each/DT
treatment/NN
group/NN
is/VBZ
depicted/VBN
in/IN
a/DT
Venn/JJ
diagram/NN
in/IN
Fig/NN
./.
====================
5/CD
./.
====================
According/VBG
to/TO
the/DT
Venn/JJ
diagram/NN
analysis/NN
,/,
105/CD
,/,
158/CD
and/CC
65/CD
genes/NNS
were/VBD
in/IN
common/JJ
between/IN
the/DT
low/JJ
and/CC
midconcentration/NN
,/,
between/IN
low/JJ
and/CC
highconcentration/JJ
and/CC
between/IN
mid/JJ
and/CC
highconcentration/JJ
,/,
respectively/RB
./.
====================
The/DT
number/NN
of/IN
common/JJ
genes/NNS
in/IN
all/DT
3/CD
treatment/NN
groups/NNS
was/VBD
26/CD
./.
====================
Out/DT
of/IN
26/CD
genes/NNS
,/,
21/CD
were/VBD
known/VBN
genes/NNS
and/CC
had/VBD
valid/JJ
annotations/NNS
./.
====================
Most/JJS
of/IN
these/DT
21/CD
common/JJ
genes/NNS
were/VBD
categorized/VBN
in/IN
“/NN
detoxification/NN
”/CD
and/CC
“/NN
immunity/NN
and/CC
defense/NN
”/CD
(/(
Table/JJ
3/CD
)/)
./.
====================
It/PRP
has/VBZ
been/VBN
demonstrated/VBN
that/IN
heavy/JJ
metals/NNS
share/VBP
common/JJ
primary/JJ
mechanisms/NNS
of/IN
toxicity/NN
,/,
including/VBG
oxidative/JJ
stress/NN
,/,
reaction/NN
with/IN
intracellular/JJ
thiols/NNS
and/CC
interference/NN
with/IN
essential/JJ
metals/NNS
(/(
Stacchiotti/NN
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
Renal/JJ
toxicity/NN
commonly/RB
occurs/VBZ
after/IN
administration/NN
of/IN
xenobiotics/NNS
,/,
including/VBG
heavy/JJ
metals/NNS
./.
====================
The/DT
process/NN
is/VBZ
typically/RB
started/VBD
by/IN
a/DT
toxic/JJ
injury/NN
to/TO
tubular/JJ
epithelial/JJ
cells/NNS
in/IN
various/JJ
nephron/NN
segments/NNS
or/CC
by/IN
injury/NN
to/TO
specific/JJ
cell/NN
types/NNS
in/IN
the/DT
glomerulus/NN
(/(
Amin/NN
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Mercuric/JJ
chloride/NN
produces/VBZ
toxic/JJ
effects/NNS
on/IN
the/DT
third/JJ
segment/NN
(/(
S3/NN
)/)
of/IN
the/DT
proximal/JJ
tubule/NN
of/IN
kidney/NN
(/(
Carranza-Rosales/NNS
et/FW
al./FW
,/,
2005/CD
)/)
./.
====================
Changes/NNS
in/IN
the/DT
expression/NN
of/IN
mRNA/NN
expressed/VBN
in/IN
the/DT
injured/JJ
kidney/NN
cells/NNS
are/VBP
some/DT
of/IN
the/DT
earliest/JJS
events/NNS
that/WDT
accompany/VBP
renal/JJ
injury/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
used/VBD
microarrays/NNS
to/TO
examine/VB
changes/NNS
in/IN
gene/NN
expression/NN
patterns/NNS
in/IN
rat/NN
tubular/JJ
epithelial/JJ
renal/JJ
cells/NNS
(/(
NRK52E/NN
)/)
after/IN
treatment/NN
of/IN
mercuric/JJ
chloride/NN
./.
====================
First/RB
,/,
we/PRP
analyzed/VBD
temporal/JJ
expression/NN
pattern/NN
and/CC
examined/VBN
overrepresented/JJ
biological/JJ
processes/NNS
for/IN
each/DT
dose/NN
treatment/NN
(/(
low/JJ
,/,
mid/JJ
and/CC
high/JJ
concentration/NN
)/)
./.
====================
For/IN
lowconcentration/JJ
treatment/NN
group/NN
,/,
it/PRP
is/VBZ
noticed/VBN
that/DT
many/JJ
genes/NNS
were/VBD
differentially/RB
expressed/VBN
and/CC
their/PRP$
related/JJ
biological/JJ
processes/NNS
(/(
5/CD
categories/NNS
)/)
were/VBD
highly/RB
overrepresented/VBN
according/VBG
to/TO
PANTHER/NN
analysis/NN
./.
====================
In/IN
particular/JJ
,/,
“/NNP
intracellular/JJ
protein/NN
traffic/JJ
”/CD
related/JJ
genes/NNS
were/VBD
highly/RB
enriched/VBN
in/IN
this/DT
group/NN
and/CC
genes/NNS
belonged/VBN
to/TO
this/DT
biological/JJ
process/NN
showed/VBD
consistent/JJ
upregulation/NN
at/IN
all/DT
time/NN
points/NNS
of/IN
lowconcentration/JJ
treatment/NN
./.
====================
A/DT
common/JJ
intracellular/JJ
effect/NN
of/IN
toxic/JJ
metals/NNS
is/VBZ
the/DT
impaired/JJ
endocytosis/NN
and/CC
intracellular/JJ
vesicle/NN
recycling/VBG
./.
====================
Mercury/NN
is/VBZ
described/VBN
to/TO
be/VB
internalized/VBN
by/IN
proximal/JJ
tubule/NN
cells/NNS
through/IN
endocytosis/NN
of/IN
mercuryprotein/NN
complex/NN
(/(
Zalups/NNS
,/,
2000/CD
)/)
./.
====================
The/DT
transcriptional/JJ
upregulations/NNS
of/IN
these/DT
genes/NNS
are/VBP
therefore/RB
considered/VBN
to/TO
reflect/VB
disturbances/NNS
in/IN
vesicle/NN
movement/NN
caused/VBD
by/IN
the/DT
mercury/NN
./.
====================
It/PRP
seems/VBZ
that/DT
the/DT
expression/NN
of/IN
“/NN
intracellular/JJ
protein/NN
traffic/JJ
”/CD
related/JJ
genes/NNS
were/VBD
consistently/RB
upregulated/VBN
at/IN
all/DT
time/NN
points/NNS
(/(
2/CD
,/,
6/CD
and/CC
12/CD
h/NN
)/)
to/TO
protect/VB
cells/NNS
from/IN
impaired/JJ
endocytosis/NN
and/CC
vesicle/NN
movement/JJ
caused/VBD
by/IN
mercury/NN
./.
====================
One/CD
highly/RB
up-regulated/VBN
gene/NN
in/IN
this/DT
group/NN
was/VBD
caveolin/NN
2/CD
(/(
＞8-fold/JJ
change/NN
)/)
,/,
which/WDT
plays/VBZ
a/DT
key/JJ
role/NN
in/IN
transcytosis/NN
of/IN
specific/JJ
membrane/NN
proteins/NNS
and/CC
ligands/NNS
in/IN
endothelial/JJ
cells/NNS
(/(
Hansen/NNP
and/CC
Nichols/NNS
,/,
2009/CD
)/)
./.
====================
Additionally/RB
,/,
our/PRP$
results/NNS
were/VBD
consistent/JJ
with/IN
a/DT
previous/JJ
report/NN
where/WRB
described/VBN
the/DT
modulation/NN
in/IN
genes/NNS
related/JJ
to/TO
“/CD
intracellular/JJ
vesicle/NN
movement/JJ
”/CD
after/IN
gentamycininduced/JJ
renal/JJ
injury/NN
(/(
Ozaki/NNP
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
For/IN
mid-concentration/NN
treatment/NN
group/NN
,/,
we/PRP
detected/VBD
an/DT
over-representation/NN
of/IN
genes/NNS
related/JJ
to/TO
“/CD
detoxification/NN
”/CD
./.
====================
Most/JJS
genes/NNS
in/IN
this/DT
category/NN
were/VBD
glutathione/NN
S-transferases/NNS
(/(
GSTs/NNS
)/)
./.
====================
GSTs/NNS
are/VBP
three/CD
enzyme/NN
families/NNS
with/IN
different/JJ
subcellular/JJ
locations/NNS
that/DT
detoxify/VBP
noxious/JJ
xenobiotics/NNS
and/CC
protect/VB
against/IN
reactive/JJ
compounds/NNS
produced/VBD
during/IN
oxidative/JJ
stress/NN
(/(
Stacchiotti/NN
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
During/IN
GST-mediated/JJ
reactions/NNS
,/,
glutathione/NN
(/(
GSH/NN
)/)
is/VBZ
conjugated/VBN
with/IN
various/JJ
electrophiles/NNS
or/CC
oxidation/NN
end/NN
product/NN
and/CC
the/DT
GSH/NN
adducts/NNS
are/VBP
actively/RB
secreted/VBN
by/IN
the/DT
cell/NN
./.
====================
This/DT
GSH-conjugated/JJ
efflux/NN
can/MD
result/VB
in/IN
the/DT
depletion/NN
of/IN
cellular/JJ
thiol/NN
./.
====================
It/PRP
is/VBZ
probable/JJ
that/DT
expression/NN
of/IN
most/JJS
GSTs/NNS
mRNA/NN
in/IN
this/DT
study/NN
increased/VBD
on/IN
6/CD
h/NN
and/CC
decreased/VBD
on/IN
12/CD
h/NN
due/JJ
to/TO
depletion/NN
of/IN
thiol/NN
in/IN
the/DT
cells/NNS
./.
====================
Glutathione/NN
S-transferage/NN
M1/NN
(/(
GSTM1/NN
)/)
mRNA/NN
level/NN
was/VBD
up-regulated/VBN
after/IN
mercuric/JJ
chloride/NN
treatment/NN
(/(
6/CD
h/NN
and/CC
12/CD
h/NN
)/)
in/IN
this/DT
study/NN
./.
====================
GSTM1/NN
gene/NN
encodes/VBZ
GST/NN
Yb1/NN
protein/NN
which/WDT
described/VBN
as/IN
urinary/JJ
leakage/NN
biomarker/NN
for/IN
distal/JJ
tubule/NN
damage/NN
(/(
Kilty/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Additionally/RB
,/,
GSTA3/NN
mRNA/NN
level/NN
was/VBD
also/RB
up-regulated/VBD
at/IN
all/DT
time/NN
points/NNS
./.
====================
α-GST/NN
is/VBZ
a/DT
cytosolic/JJ
enzyme/NN
expressed/VBN
in/IN
the/DT
epithelial/JJ
cells/NNS
of/IN
the/DT
proximal/JJ
tubule/NN
(/(
Sundberg/NN
et/FW
al./FW
,/,
1994/CD
)/)
./.
====================
The/DT
appearance/NN
of/IN
α/JJ
GST/NN
in/IN
urine/NN
is/VBZ
thought/VBN
to/TO
result/VB
from/IN
the/DT
leakage/NN
of/IN
cytosolic/JJ
contents/NNS
when/WRB
proximal/JJ
tubule/NN
epithelial/JJ
cells/NNS
die/VBP
(/(
Ferguson/NN
et/FW
al./FW
,/,
2008/CD
;/:
Vaidya/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
Upregulation/NN
of/IN
GSTs/NNS
mRNA/NN
in/IN
our/PRP$
study/NN
was/VBD
concomitant/JJ
with/IN
a/DT
previous/JJ
study/NN
which/WDT
demonstrated/VBD
activation/NN
of/IN
this/DT
enzyme/NN
after/IN
mercury/NN
and/CC
lead/VBP
treatment/NN
(/(
Stacchiotti/NN
et/FW
al./FW
,/,
2009/CD
)/)
./.
====================
Many/JJ
Genes/NNS
(/(
2,499/CD
genes/NNS
)/)
that/WDT
were/VBD
significantly/RB
regulated/VBN
by/IN
high-concentration/JJ
mercuric/JJ
chloride/NN
treatment/NN
grouped/VBD
into/IN
7/CD
major/JJ
functional/JJ
categories/NNS
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
These/DT
genes/NNS
were/VBD
shown/VBN
to/TO
be/VB
associated/VBN
with/IN
the/DT
apoptotic/JJ
and/or/CC
necrotic/JJ
effect/NN
of/IN
mercuric/JJ
chloride/NN
./.
====================
Of/IN
these/DT
genes/NNS
,/,
heme/NN
oxygenase/NN
1/CD
(/(
HMOX1/NN
)/)
and/CC
activating/VBG
transcription/NN
factor/NN
3/CD
(/(
ATF3/NN
)/)
showed/VBD
remarkable/JJ
over/IN
expression/NN
(/(
more/RBR
than/IN
8-fold/JJ
)/)
by/IN
highconcentration/JJ
treatment/NN
at/IN
all/DT
3/CD
time/NN
points/NNS
./.
====================
HMOX1/NN
was/VBD
previously/RB
reported/VBD
to/TO
be/VB
induced/VBN
in/IN
kidney/NN
following/VBG
toxic/JJ
and/CC
ischemic/JJ
insults/NNS
(/(
Nath/NN
,/,
2006/CD
,/,
Takahashi/NNP
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Up-regulation/NN
of/IN
ATF3/NN
mRNA/NN
was/VBD
also/RB
reported/VBD
previously/RB
to/TO
be/VB
induced/VBN
by/IN
gentamycin/NN
treatment/NN
and/CC
after/IN
ischemic/JJ
and/CC
nephrotoxic/JJ
acute/JJ
renal/JJ
failure/NN
(/(
Ozaki/NNP
et/FW
al./FW
,/,
2009/CD
,/,
Yuen/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
We/PRP
detected/VBD
21/CD
known/VBN
genes/NNS
common/JJ
in/IN
all/DT
3/CD
concentration/NN
treatment/NN
group/NN
./.
====================
Most/JJS
of/IN
them/PRP
were/VBD
classified/VBN
into/IN
“/NN
detoxification/NN
”/CD
//:
“/NN
immunity/NN
and/CC
defense/NN
”/CD
category/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
Early/JJ
growth/NN
response/NN
1/CD
(/(
EGR1/NN
)/)
,/,
one/CD
of/IN
the/DT
common/JJ
genes/NNS
was/VBD
reported/VBN
in/IN
previous/JJ
study/NN
that/IN
expression/NN
of/IN
EGR1/NN
,/,
a/DT
zincfinger/NN
transcription/NN
factor/NN
,/,
increased/VBD
by/IN
oxalate/JJ
treatment/NN
on/IN
the/DT
porcine/NN
renal/JJ
epithelial/JJ
LLCPK1/NN
cell/NN
line/NN
(/(
Jonassen/NNP
et/FW
al./FW
,/,
1999/CD
)/)
./.
====================
NAD/NN
(/(
P/NN
)/)
H/NN
dehydrogenase/NN
,/,
quinone/RB
1/CD
(/(
NQO1/NN
)/)
,/,
another/DT
gene/NN
in/IN
common/JJ
group/NN
,/,
has/VBZ
been/VBN
reported/VBN
to/TO
show/VB
increased/VBD
protein/NN
expression/NN
and/CC
activity/NN
after/IN
treatment/NN
of/IN
iron/NN
nitrilotriacetate/NN
(/(
FeNTA/NN
)/)
./.
====================
This/DT
induces/VBZ
acute/JJ
proximal/JJ
tubular/JJ
necrosis/NN
as/IN
a/DT
consequence/NN
of/IN
lipid/NN
peroxidation/NN
and/CC
oxidative/JJ
tissue/NN
damage/NN
(/(
Tanaka/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
In/IN
our/PRP$
study/NN
,/,
we/PRP
did/VBD
not/RB
identify/VB
deregulation/NN
of/IN
KIM1/NN
,/,
which/WDT
is/VBZ
reported/VBN
as/IN
a/DT
sensitive/JJ
maker/RB
of/IN
renal/JJ
injury/NN
induced/VBD
by/IN
a/DT
variety/NN
of/IN
agent/JJ
including/VBG
cisplatin/JJ
,/,
S/NNP
(/(
1/LS
,/,
1/LS
,/,
2/CD
,/,
2tetrafluorethyl/JJ
)/)
Lcysteine/JJ
,/,
folic/JJ
acid/NN
(/(
Ichimura/NNP
et/FW
al./FW
,/,
2004/CD
,/,
Vaidya/NNP
et/FW
al./FW
,/,
2006/CD
)/)
,/,
Hg/NNP
(/(
Zhou/NNP
et/FW
al./FW
,/,
2008/CD
)/)
,/,
chromium/NN
(/(
Zhou/NNP
et/FW
al./FW
,/,
2008/CD
)/)
,/,
cadimium/NN
(/(
Prozialeck/NNP
et/FW
al./FW
,/,
2009/CD
)/)
and/CC
cyclosporine/NN
(/(
P/NN
?/.
rezRojas/RB
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
Since/IN
the/DT
alteration/NN
of/IN
KIM1/NN
in/IN
these/DT
studies/NNS
was/VBD
depicted/VBN
by/IN
using/VBG
in/IN
vivo/FW
model/NN
not/RB
in/IN
vitro/FW
model/NN
,/,
it/PRP
seems/VBZ
that/DT
missing/VBG
of/IN
KIM1/NN
modulation/NN
in/IN
current/JJ
study/NN
resulted/VBD
from/IN
the/DT
difference/NN
between/IN
model/NN
systems/NNS
./.
====================
In/IN
summary/NN
,/,
we/PRP
were/VBD
able/JJ
to/TO
identify/VB
a/DT
number/NN
of/IN
genes/NNS
which/WDT
showed/VBD
significant/JJ
changes/NNS
at/IN
mRNA/NN
level/NN
in/IN
response/NN
to/TO
mercuric/JJ
chloride/NN
,/,
a/DT
model/NN
nephrotoxicant/JJ
./.
====================
Most/JJS
interestingly/RB
,/,
some/DT
of/IN
the/DT
genes/NNS
(/(
e./FW
g./FW
GSTM1/NN
,/,
HMOX1/NN
,/,
ATF3/NN
and/CC
EGR1/NN
)/)
were/VBD
previously/RB
reported/VBD
to/TO
be/VB
induced/VBN
in/IN
proximal/JJ
tubule/NN
cells/NNS
after/IN
chemical/JJ
insults/NNS
on/IN
kidney/NN
./.
====================
Our/PRP$
study/NN
provided/VBD
supporting/VBG
evidences/VBZ
at/IN
molecular/JJ
level/NN
for/IN
these/DT
previously/RB
reported/VBD
putative/JJ
nephrotoxicity/NN
biomarker/NN
./.
====================
However/RB
it/PRP
will/MD
be/VB
needed/VBN
additional/JJ
studies/NNS
on/IN
reversibility/NN
,/,
specificity/NN
and/CC
sensitivity/NN
of/IN
the/DT
putative/JJ
biomarkers/NNS
to/TO
be/VB
validated/VBN
./.
====================
